Risk Factors for Severe Hypertension and Proteinuria after Treatment with Vascular Endothelial Growth Factor Signaling Pathway Inhibitors among Patients with Cancer Kidney International Reports doi: 10.1016/j.ekir.2024.03.005
Date
03/13/2024Author List
Hanna PE, Anumolu RK, Motwani SS, Chen KL, Katz-Agranov N, Green-Lingren O, Yilmam OA, Jhaveri KD, Kitchlu A, Kala J, Sise ME, Gupta SAuthor
Paul E. Hanna MD Assistant Professor in the Medicine department at Medical College of WisconsinView Online
